MSD launches Clostridium difficile antitoxin in the UK
MSD has launched Zinplava in the UK, offering patients a novel therapeutic option for the prevention of Clostridium difficile recurrence.
Read More
Tag: clostridium difficile
Sanofi ends development of Clostridium difficile vaccine
Sanofi has pulled the plug on its experimental Clostridium difficile vaccine after an interim analysis of a late-stage trial concluded that key targets were unlikely to be met.
Read More
US delay to Merck’s C.difficile antitoxin
Merck & Co’s investigational clostridium difficile treatment has been hit with a setback in the US after regulators extended the review time for the drug by three months.
Read More
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
